Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Exploratory Study on the Efficacy of Neoadjuvant Chemoradiotherapy Combined With QL1706 in Patients With MSS-type Low-stage Rectal Cancer

NCT07866313 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT07866313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07866313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Exploratory Study on the Efficacy of Neoadjuvant Chemoradiotherapy Combined With QL1706 in Patients With MSS-type Low-stage Rectal Cancer
Lead sponsor
Changhai Hospital
Phase
Phase 2/3
Overall status
Recruiting
Start date
June 1, 2026
Completion date
December 1, 2031
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mss-type low rectal cancer，neoadjuvant chemoradiotherapy, ql1706